Menopausal symptoms among breast cancer patients 6 months after diagnosis: a report from the Shanghai Breast Cancer Survival Study

被引:30
作者
Dorjgochoo, Tsogzolmaa [1 ]
Gu, Kai [2 ]
Kallianpur, Asha [1 ]
Zheng, Ying [2 ]
Zheng, Wei [1 ]
Chen, Zhi [1 ]
Lu, Wei [2 ]
Shu, Xiao Ou [1 ]
机构
[1] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Vanderbilt Epidemiol Ctr,Dept Med, Nashville, TN 37203 USA
[2] Shanghai Inst Prevent Med, Shanghai, Peoples R China
来源
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY | 2009年 / 16卷 / 06期
基金
美国国家卫生研究院;
关键词
Menopausal symptoms; Breast cancer; Chemotherapy; Immunotherapy; Tamoxifen; Radiotherapy; Age; Menopause; Body mass index; Chronic disease; Quality of life; Chinese women; QUALITY-OF-LIFE; VASOMOTOR SYMPTOMS; ADJUVANT CHEMOTHERAPY; POSTMENOPAUSAL WOMEN; YOUNGER WOMEN; HOT FLASHES; PREVALENCE; HEALTH; TAMOXIFEN; THERAPY;
D O I
10.1097/gme.0b013e3181aac32b
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: The aim of this study was to estimate the prevalence of menopausal symptoms in relation to treatment modalities in Asian women treated for breast cancer. Methods: A population-based cohort of 5,023 Chinese women aged 25 to 70 years with primary stage 0 to III breast cancer was identified from a population-based tumor registry and enrolled in the study approximately 6 months after diagnosis. Participants were asked about the occurrence of specific menopausal symptoms. Associations between these symptoms and breast cancer treatments were evaluated by stratified, multivariate logistic regression. Results: Among women with a recent diagnosis of breast cancer, 67.2% of premenopausal women and 46.3% of postmenopausal women experienced at least one menopausal symptom, namely, hot flashes, night sweats, and/or vaginal dryness. Symptom prevalence among postmenopausal women decreased progressively with age at diagnosis (63.3% for women aged 51-55 y, 51.5% for women aged 56-60 y, and 34.4% for women aged >65 y; P < 0.01). Overall, the highest prevalence of most symptoms occurred in women aged 46 to 55 years (P < 0.01). Chemotherapy was positively associated with the occurrence of any symptom and with each individual symptom, mainly in premenopausal women (adjusted odds ratio [OR] range, 2.2-3.3; P < 0.05 for all). Tamoxifen use and immunotherapy were associated with having any symptom and with each individual symptom, regardless of menopause status (adjusted OR range, 1.5-1.8 and 1.3-1.5, respectively; P < 0.05 for all). Women treated before menopause were at particularly high risk of experiencing two or more symptoms after chemotherapy (OR, 1.77; 95% CI, 1.54-4.98; P-interaction = 0.05) compared with postmenopausal women. Conclusions: Menopausal symptoms are prevalent among Chinese women recently treated for primary breast cancer. These symptoms are associated with age and menopause status at the time of diagnosis, as well as with the type of treatment received.
引用
收藏
页码:1205 / 1212
页数:8
相关论文
共 44 条
[1]   Is there a menopausal syndrome? Menopausal status and symptoms across racial/ethnic groups [J].
Avis, NE ;
Stellato, R ;
Crawford, S ;
Bromberger, J ;
Ganz, P ;
Cain, V ;
Kagawa-Singer, M .
SOCIAL SCIENCE & MEDICINE, 2001, 52 (03) :345-356
[2]   Update in female reproduction: A life-cycle approach [J].
Barbieri, Robert L. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (07) :2439-2446
[3]   Menopause after breast cancer: a survey on breast cancer survivors [J].
Biglia, N ;
Cozzarella, M ;
Cacciari, F ;
Ponzone, R ;
Roagna, R ;
Maggiorotto, F ;
Sismondi, P .
MATURITAS, 2003, 45 (01) :29-38
[4]   Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer [J].
Bines, J ;
Oleske, DM ;
Cobleigh, MA .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (05) :1718-1729
[5]  
Canney P A, 1994, Clin Oncol (R Coll Radiol), V6, P297, DOI 10.1016/S0936-6555(05)80270-5
[6]  
Carpenter J S, 1999, Oncol Nurs Forum, V26, P1311
[7]   Sleep, fatigue, and depressive symptoms in breast cancer survivors and matched healthy women experiencing hot flashes [J].
Carpenter, JS ;
Elam, JL ;
Ridner, SH ;
Carney, PH ;
Cherry, GJ ;
Cucullu, HL .
ONCOLOGY NURSING FORUM, 2004, 31 (03) :591-598
[8]  
Carpenter JS, 1998, CANCER-AM CANCER SOC, V82, P1682, DOI 10.1002/(SICI)1097-0142(19980501)82:9<1682::AID-CNCR14>3.0.CO
[9]  
2-0
[10]   PREVALENCE OF MENOPAUSAL SYMPTOMS AMONG WOMEN WITH A HISTORY OF BREAST-CANCER AND ATTITUDES TOWARD ESTROGEN REPLACEMENT THERAPY [J].
COUZI, RJ ;
HELZLSOUER, KJ ;
FETTING, JH .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (11) :2737-2744